Why the study?
Does measurement of hs-TnT in the plateau phase after STEMI provide prognostic risk assessment?
Does measurement of hs-TnT in the plateau phase after STEMI provide prognostic risk assessment?
Measurement of hs-TnT in the plateau phase after STEMI provides an inexpensive method for prognostic risk assessment.
Answers are grounded in this paper and cite their sources.
May support plateau-phase hs-TnT use for post-STEMI risk stratification; extends randomized evidence for high-sensitivity troponin prognostication.
Measurement of hs-TnT in the plateau phase after STEMI is an inexpensive method of prognostic risk assessment.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: